Efficacy and Safety of MK-1942 as an Adjunct Therapy in Participants With Mild to Moderate Alzheimer's Disease Dementia (MK-1942-008)
Clinical trial NCT05602727 · TERMINATED
Trial details
- NCT number
- NCT05602727
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2023-09-27
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.